| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Karuna Therapeutics, Inc. | Director | Common Stock | 6,556 | $2,077,006 | $316.81 | 24 Jun 2021 | Direct |
| Karuna Therapeutics, Inc. | Director | Option (right to buy) | 8,500 | $939,250 | $110.50 | 16 Jun 2021 | Direct |
| Fusion Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 17,000 | 14 Jun 2023 | Direct | ||
| Aligos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 5,860 | 25 Jun 2025 | Direct | ||
| Akouos, Inc. | Director | Common Stock | 0 | $12.50 | 30 Nov 2022 | Direct | |
| Akouos, Inc. | Director | Stock Option (right to buy) | 0 | 01 Dec 2022 | Direct |